Metabolism of Levodopa in Patients With Parkinson's Disease
- 1 July 1971
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 25 (1) , 39-44
- https://doi.org/10.1001/archneur.1971.00490010049007
Abstract
The distribution of carbon 14 labeled levodopa and its metabolites was examined in six patients with Parkinson's disease after oral dosage. Levodopa is well absorbed giving maximum plasma concentrations one to two hours after dosage. Measurable levodopa is in plasma for four to six hours after a single dose. At maximum levels, however, levodopa constituted only 10% of plasma radioactivity. Small amounts of radioactivity were found in the cerebrospinal fluid two hours after dosage (partly as homovanillic acid), while 85% of the dose was recovered in urine in 24 hours. Less than 1% of the dose is recovered in the urine as unchanged levodopa. Simultaneous feeding of milk to one subject apparently delayed absorption of levodopa and may have allowed more extensive degradation of the drug in the gastrointestinal tract.Keywords
This publication has 9 references indexed in Scilit:
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- Drug-Induced Changes of Extracerebral Dopa Metabolism in ManArchives of Neurology, 1969
- 5 The Biosynthesis and Metabolism of the CatecholaminesProgress in Medicinal Chemistry, 1969
- Measurement of acid monoamine metabolites in human and animal cerebrospinal fluidJournal of Neurochemistry, 1968
- Metabolic fate of L-[14C] DOPA in cerebrospinal fluid and blood plasma of humansBrain Research, 1967
- On the origin of homovanillic acid in the cerebrospinal fluidCellular and Molecular Life Sciences, 1966
- Absorption of protein digestion products: a review.Gut, 1965
- The Direct Demonstration of a Barrier Mechanism in the Brain CapillariesActa Pharmacologica et Toxicologica, 1964
- Properties of a Carrier System to transport L–Dopa into Brain SlicesNature, 1963